ALLMedicine™ Ulcerative Colitis Center
Research & Reviews 20,717 results
https://doi.org/10.1136/bcr-2021-242154
BMJ Case Reports; Chong WH, Ibrahim A et. al.
Apr 13th, 2021 - Not all nodules with PET hypermetabolic activity are malignant: a case of lung granuloma in ulcerative colitis.|2021|Chong WH,Ibrahim A,Saha BK,|
https://doi.org/10.1186/s12876-021-01747-z 10.1016/S0889-8553(01)00002-4 10.1016/j.mayocp.2014.07.002 10.1016/S0140-6736(16)32126-2 10.1038/nature06005 10.1097/01.mib.0000179467.01748.99 10.1097/01.MIB.0000159661.55028.56 10.1111/j.1365-2036.2004.1873.x 10.1111/jgh.13795 10.1097/01.MIB.0000218762.61217.4a 10.1136/gutjnl-2012-302311 10.1097/MEG.0000000000000685 10.1097/01.mcg.0000159220.70290.41 10.1093/ecco-jcc/jjv081 10.1038/ajg.2015.233 10.1111/j.1365-2036.2010.04234.x 10.1080/00365520600664250 10.1016/j.crohns.2012.02.017 10.2165/00019053-200422040-00002 10.1055/a-1015-7265 10.1155/2011/938194 10.1056/NEJMoa050516 10.1002/ibd.20165 10.1186/s41687-018-0088-8 10.1016/j.clinthera.2008.02.016 10.1093/rheumatology/kep457 10.1016/0016-5085(94)90585-1 10.1055/s-2005-858579 10.1097/00005650-199603000-00003 10.1002/ibd.20520 10.3748/wjg.v26.i21.2852 10.1007/s11938-014-0044-5 10.2147/CEG.S4512 10.1016/j.cgh.2018.04.007 10.1159/000508865
BMC Gastroenterology; Teich N, Grümmer H et. al.
Apr 13th, 2021 - Ulcerative colitis (UC) is a chronic inflammatory bowel disease with recurrent episodes of debilitating symptoms negatively affecting work productivity and health-related quality of life (HRQoL). The use of biologics in UC treatment improves work ...
https://doi.org/10.1093/ibd/izab063
Inflammatory Bowel Diseases; Manzini R, Schwarzfischer M et. al.
Apr 13th, 2021 - Vedolizumab is a widely used and safe therapy in inflammatory bowel disease, particularly in ulcerative colitis (UC), making it a promising candidate for enhanced efficacy by combining it with additional immunomodulatory medications. In this study...
https://doi.org/10.1093/ibd/izab062
Inflammatory Bowel Diseases; Asonuma K, Kobayashi T et. al.
Apr 13th, 2021 - Mucosal healing is a treatment target for patients with ulcerative colitis. However, the relevance of proactive treatment for residual inflammation limited to the distal colon is unclear. Patients with ulcerative colitis who had extensive colitis ...
https://doi.org/10.1080/01635581.2021.1909737
Nutrition and Cancer; Mashtoub S, Chartier LC et. al.
Apr 12th, 2021 - Ulcerative colitis patients have an increased risk of developing colorectal cancer (CRC). The aim of the current study was to determine whether Emu Oil (EO) could reduce the severity of colitis, thereby inhibiting colitis-associated CRC (CA-CRC) d...
Guidelines 87 results
https://doi.org/10.1016/j.gastrohep.2020.05.009
Annals of the New York Academy of Sciences References; Muñoz F, Ripollés T et. al.
Sep 26th, 2020 - Ultrasound has an excellent diagnostic performance when Crohn's disease is suspected, when performing an activity assessment, or determining the extension and location of Crohn's disease, very similar to other examinations such as MRI or CT. It ha...
https://doi.org/10.1053/j.gastro.2020.03.011
Gastroenterology
Mar 28th, 2020 - Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.|2020| ,|
https://doi.org/10.1053/j.gastro.2020.03.012
Gastroenterology Feuerstein JD, Isaacs KL et. al.
Mar 14th, 2020 - Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175923
Gastroenterology Feuerstein JD, Isaacs KL et. al.
Jan 16th, 2020 - AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.|2020|Feuerstein JD,Isaacs KL,Schneider Y,Siddique SM,Falck-Ytter Y,|therapeutic use,standards,diagnosis,immunology,therapy,diagnostic imaging,immunology,p...
https://doi.org/10.1136/bmj.l5897
BMJ (Clinical Research Ed.); Abdulrazeg O, Li B et. al.
Oct 29th, 2019 - Management of ulcerative colitis: summary of updated NICE guidance.|2019|Abdulrazeg O,Li B,Epstein J, ,|drug therapy,methods,therapeutic use,drug therapy,drug therapy,
Drugs 289 results see all →
Clinicaltrials.gov 21,799 results
https://doi.org/10.1136/bcr-2021-242154
BMJ Case Reports; Chong WH, Ibrahim A et. al.
Apr 13th, 2021 - Not all nodules with PET hypermetabolic activity are malignant: a case of lung granuloma in ulcerative colitis.|2021|Chong WH,Ibrahim A,Saha BK,|
https://doi.org/10.1186/s12876-021-01747-z 10.1016/S0889-8553(01)00002-4 10.1016/j.mayocp.2014.07.002 10.1016/S0140-6736(16)32126-2 10.1038/nature06005 10.1097/01.mib.0000179467.01748.99 10.1097/01.MIB.0000159661.55028.56 10.1111/j.1365-2036.2004.1873.x 10.1111/jgh.13795 10.1097/01.MIB.0000218762.61217.4a 10.1136/gutjnl-2012-302311 10.1097/MEG.0000000000000685 10.1097/01.mcg.0000159220.70290.41 10.1093/ecco-jcc/jjv081 10.1038/ajg.2015.233 10.1111/j.1365-2036.2010.04234.x 10.1080/00365520600664250 10.1016/j.crohns.2012.02.017 10.2165/00019053-200422040-00002 10.1055/a-1015-7265 10.1155/2011/938194 10.1056/NEJMoa050516 10.1002/ibd.20165 10.1186/s41687-018-0088-8 10.1016/j.clinthera.2008.02.016 10.1093/rheumatology/kep457 10.1016/0016-5085(94)90585-1 10.1055/s-2005-858579 10.1097/00005650-199603000-00003 10.1002/ibd.20520 10.3748/wjg.v26.i21.2852 10.1007/s11938-014-0044-5 10.2147/CEG.S4512 10.1016/j.cgh.2018.04.007 10.1159/000508865
BMC Gastroenterology; Teich N, Grümmer H et. al.
Apr 13th, 2021 - Ulcerative colitis (UC) is a chronic inflammatory bowel disease with recurrent episodes of debilitating symptoms negatively affecting work productivity and health-related quality of life (HRQoL). The use of biologics in UC treatment improves work ...
https://doi.org/10.1093/ibd/izab063
Inflammatory Bowel Diseases; Manzini R, Schwarzfischer M et. al.
Apr 13th, 2021 - Vedolizumab is a widely used and safe therapy in inflammatory bowel disease, particularly in ulcerative colitis (UC), making it a promising candidate for enhanced efficacy by combining it with additional immunomodulatory medications. In this study...
https://doi.org/10.1093/ibd/izab062
Inflammatory Bowel Diseases; Asonuma K, Kobayashi T et. al.
Apr 13th, 2021 - Mucosal healing is a treatment target for patients with ulcerative colitis. However, the relevance of proactive treatment for residual inflammation limited to the distal colon is unclear. Patients with ulcerative colitis who had extensive colitis ...
https://doi.org/10.1080/01635581.2021.1909737
Nutrition and Cancer; Mashtoub S, Chartier LC et. al.
Apr 12th, 2021 - Ulcerative colitis patients have an increased risk of developing colorectal cancer (CRC). The aim of the current study was to determine whether Emu Oil (EO) could reduce the severity of colitis, thereby inhibiting colitis-associated CRC (CA-CRC) d...
News 1,165 results
https://www.medscape.com/viewarticle/946797
Mar 2nd, 2021 - Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis (UC), according to a press release from manufacturer AbbVie. Approval...
https://www.medscape.com/viewarticle/946588
Feb 28th, 2021 - NEW YORK (Reuters Health) - The recently developed Paddington International Virtual ChromoendoScopy ScOre (PICaSSO) accurately identified both endoscopic and histologic remission in ulcerative colitis (UC) and predicted specified clinical outcomes...
https://www.medscape.com/viewarticle/946043
Feb 18th, 2021 - NEW YORK (Reuters Health) - The monoclonal antibody ustekinumab (Stelara, Janssen) appears to be at least as effective against ulcerative colitis (UC) in real-world practice as it was in the clinical trials that led to its approval, according to n...
https://www.fda.gov/safety/medical-product-safety-information/xeljanz-xeljanz-xr-tofacitinib-drug-safety-communication-initial-safety-trial-results-find-increased
[Posted 02/04/2021] AUDIENCE: Patient, Health Professional, Pharmacy, Rheumatology, Gastroenterology, Cardiology, Oncology ISSUE: The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serio...
https://www.medscape.com/viewarticle/945009
Feb 1st, 2021 - NEW YORK (Reuters Health) - For iron-deficiency anemia (IDA) in patients with inflammatory bowel disease (IBD), intravenous ferric carboxymaltose is probably a better bet than IV iron sucrose, according to a Cochrane review of therapies to treat I...
